4//SEC Filing
Loew Caroline 4
Accession 0000950170-25-033766
CIK 0001971543other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:48 PM ET
Size
10.2 KB
Accession
0000950170-25-033766
Insider Transaction Report
Form 4
Loew Caroline
DirectorChief Executive Officer
Transactions
- Award
Ordinary Shares
2025-03-03+72,275→ 309,903 total - Sale
Ordinary Shares
2025-03-04$3.36/sh−4,313$14,492→ 305,590 total - Award
Stock Option (right to buy)
2025-03-03+134,225→ 134,225 totalExercise: $3.43Exp: 2035-03-02→ Ordinary Shares (134,225 underlying)
Footnotes (5)
- [F1]Consists of ordinary shares issuable under 72,275 restricted stock units ("RSUs"). Each RSU represents the right to receive one ordinary share upon vesting. The RSUs are scheduled to vest with respect to 25% of the underlying ordinary shares on each of the first four anniversaries of March 3, 2025, subject to the reporting person's continued service with the Issuer.
- [F2]Includes 189,693 restricted stock units.
- [F3]Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on March 1, 2024. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement that includes a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 that was entered into on March 27, 2024, and the sale does not represent a discretionary trade by the Reporting Person.
- [F4]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.35 to $3.36. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]This option was granted on March 3, 2025. The option is scheduled to vest with respect to 25% of the underlying ordinary shares on March 3, 2026 and the remaining 75% of the underlying ordinary shares shall vest in 12 equal quarterly installments thereafter, subject to the reporting person's continued services with the Issuer.
Documents
Issuer
Mural Oncology plc
CIK 0001971543
Entity typeother
Related Parties
1- filerCIK 0001989488
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:48 PM ET
- Size
- 10.2 KB